tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Brendan Smith, 22 are a BUY (62.86%), 13 are a HOLD (37.14%).
Analyst Brendan Smith, currently employed at TD COWEN, carries an average stock price target met ratio of 69.7% that have a potential upside of 13.87% achieved within 56 days.
Brendan Smith’s has documented 72 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HALO, Halozyme Therapeutics at 07-Aug-2026.
Analyst best performing recommendations are on SLP (SIMULATIONS PLUS).
The best stock recommendation documented was for NVAX (NOVAVAX) at 8/4/2025. The price target of $8 was fulfilled within 3 days with a profit of $1.25 (18.52%) receiving and performance score of 61.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-May-2021
$37
$-1.75 (-4.52%)
$37
22 days ago
(14-Sep-2026)
7/31 (22.58%)
$4.96 (15.48%)
100
Buy Since 05-Feb-2026
$35
$-3.75 (-9.68%)
$35
2 months ago
(06-Aug-2026)
12/15 (80%)
$4.26 (13.86%)
84
Buy Since 04-Feb-2026
$40
$14.5 (56.86%)
$38
8 months 2 days ago
(04-Feb-2026)
1/3 (33.33%)
$11.51 (40.40%)
26
Hold Since 27-Feb-2025
$39
$13.5 (52.94%)
$35
8 months 28 days ago
(08-Jan-2026)
3/4 (75%)
$1.5 (4.00%)
36
Buy Since 25-Nov-2025
$45
$19.5 (76.47%)
$35
10 months 11 days ago
(25-Nov-2025)
1/2 (50%)
$6.9 (18.11%)
110
Which stock is Brendan Smith most bullish on?
Which stock is Brendan Smith most reserved on?
What Year was the first public recommendation made by Brendan Smith?
